Latest Content

Stephen Greene, MD, discusses the future and practical implications of optimizing quadruple foundational therapies for patients with heart failure.

This article examines how prices, insurer payments, and patient payments for outpatient surgeries differ by site of care and network status.

Research highlights disparities in anti-obesity medication use and metabolic and bariatric surgery.

An epidemic resurgence is possible in Zambia should rapid restoration of HIV services not be conducted.

FDA approvals since the last Skin of Color Update expand topical and biologic options for various dermatological conditions, benefiting patients with skin of color.

This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.

The European Association for the Study of Obesity now recommends the 2 treatments for obesity and most associated complications.

The second dose of influenza vaccine was less effective overall when the studied cohort was expanded to any child younger than 9 years.

The FDA has approved a second generic version of oral mifepristone, used to terminate pregnancy, after determining it is identical to the branded drug.